Surrozen Inc
Biotechnology
Healthcare
SRZN
3.23 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
9.98
52 week high
17.02
high
10.22
52 week low
6.55
low
8.84
growth
-15.70 %
previous Close
9.35
P/E ratio
market cap
45.17 M
div yield
0
usd
Sep 2024
qoq
revenue
10.00 M
0.00 %
net incoming
-1.43 M
94.32 %
eps
0.00 %
71.43 %
eps surprise
84.12 %
net profit margin
-14.34 %
-14.00 %
operating incoming
1.23 M
113.61 %
net change in cash
-6.75 M
-164.47 %
cash on hand
31.01 M
-17.88 %
cost of revenue
0.00 %
top top